ADC Therapeutics SA (ADCT) Operating cash flow 2022–2025
ADC Therapeutics SA (ADCT) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$141.2MFY2025 · since FY2022: -$138.3M → -$141.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$141.2M | -14.0% |
| FY2024 | -$123.8M | -4.3% |
| FY2023 | -$118.7M | +14.2% |
| FY2022 | -$138.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice